Kroenke, Candyce H
Research interests include social, psychological, and lifestyle factors and breast cancer.
Research interests include social, psychological, and lifestyle factors and breast cancer.
Research interests include nutritional epidemiology.
Research interests include epidemiology of breast cancer prognosis.
Research interests include dietary and anthropometric risk factors for cancer and cancer survival.
Improving breast cancer risk prediction models could enable more personalized screening. This would enhance the benefits of screening while limiting…
The goal of this project is to determine whether Ki-67 testing, using newer methods, could be used as a replacement…
This application will use the Pathways Study resource to investigate genetic and non-genetic factors in the interplay of energy balance,…
Social pain and physical pain are related bidirectionally, but how these variables cluster in the population is unknown. This study…
We will assess the incidence and severity of breast white adipose tissue (B-WAT) inflammation in mastectomy specimens from approximately 1,900…
To strengthen the dietary guidelines for breast cancer survivors, we examine whether at-diagnosis concordance with healthful dietary patterns is associated…
This funding expands on neighborhood resources developed under the U01 grant (geocoded residential histories, linkage to census and area databases,…
This project expands a consortium of studies examining germline genetic mutations in breast cancer risk in Latinas. It builds on…
Background: As social and built environment factors have been shown to be associated with physical activity, dietary patterns, and obesity…
Little research examines whether adiposity or post-diagnosis weight changes influence Cardiovascular disease (CVD) among breast cancer patients for whom effects…
This grant provides core infrastructure support for the Pathways Study (Kushi, PI), a prospective cohort study of breast cancer survivorship…
Lifestyle factors may be associated with chemotherapy-induced peripheral neuropathy (CIPN). We examined associations between body mass index (BMI) and lifestyle…
The majority of breast cancer patients receive endocrine therapy, including aromatase inhibitors known to cause increased bone resorption. Bone-related biomarkers…
This is the largest prospective cohort study of women who are newly diagnosed with breast cancer, in which we examine…
To investigate whether the impact of postdiagnosis exercise on breast cancer outcomes in women diagnosed with early-stage breast cancer differs…
For many women with non-metastatic breast cancer, adjuvant chemotherapy prevents recurrence and extends survival. Women who discontinue chemotherapy early may…
Breast cancer chemotherapy toxicity is not well documented outside of randomized trials. We developed and conducted preliminary evaluation of an…
Integrated health care delivery systems, with their comprehensive and integrated electronic medical records (EMR), are well-poised to conduct research that…
One year of trastuzumab therapy is recommended for women with HER2-positive breast cancer ? 1.0 cm in size to increase…
Data are lacking to describe gene expression-based breast cancer intrinsic subtype patterns for population-based patient groups. We studied a diverse…
The PAM50, a gene expression assay to categorize breast tumors into intrinsic subtypes, has not been previously used to examine…
To evaluate whether differences in PAM50 breast cancer (BC) intrinsic (Luminal A, Luminal B, Basal-like, and HER2-enriched) subtypes help explain…
A cross-sectional study was performed to assess bone health history among aromatase inhibitor (AI) users before breast cancer (BC) diagnosis,…
Shared breast cancer treatment decision-making between patients and physicians increases patient treatment satisfaction and compliance and is influenced by physician-related…
BACKGROUND: Little is known about the development of posttraumatic stress disorder (PTSD) over time among women diagnosed with breast cancer…
Patients are increasingly involved in cancer treatment decisions and yet little research has explored factors that may affect patient attitudes…
Chemotherapy regimens for early stage breast cancer have been tested by randomized clinical trials, and specified by evidence-based practice guidelines…
PURPOSE: For some women, adjuvant chemotherapy for nonmetastatic breast cancer decreases recurrences and increases survival; however, patient-physician decisions regarding chemotherapy…
Adjuvant hormonal therapy for non-metastatic hormone receptor (HR)-positive breast cancer decreases risk of breast cancer recurrence and increases survival. However,…
In oncology, quality of care is a major issue for patients and providers. Significant variations in care, including nonreceipt of…
Mortality after breast cancer diagnosis is known to vary by race/ethnicity even after adjustment for differences in tumor characteristics. As…
Despite the benefit of adjuvant hormonal therapy (HT) on mortality among women with breast cancer (BC), many women are non-adherent…
Multiple-day diet records can be unsuitable for cohort studies because of high administrative and analytical costs. Costs could be reduced…
OBJECTIVE: To determine the incidence of breast cancer-related lymphedema (BCRL) during the early survivorship period as well as demographic, lifestyle,…
Although tumor size and lymph node involvement are the current cornerstones of breast cancer prognosis, they have not been extensively…